Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071006
Status:
COMPLETED
Last Update Posted:
2012-06-08
First Post:
2003-10-09
Brief Title:
AG-013736 Axitinib In Patients With Poor Prognosis Acute Myeloid Leukemia AML Or Myelodysplastic Syndrome MDS
Sponsor:
Pfizer
Organization:
Pfizer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
| Acute Myeloid Leukemia AML |
Keywords: